Cardiac Magnetic Resonance in the Evaluation of COVID-19.
Card Fail Rev
; 8: e09, 2022 Jan.
Article
in English
| MEDLINE | ID: covidwho-1786388
ABSTRACT
Cardiovascular involvement following COVID-19 is heterogeneous, prevalent and is often missed by echocardiography and serum biomarkers (such as troponin I and brain natriuretic peptide). Cardiac magnetic resonance (CMR) is the gold standard non-invasive imaging modality to phenotype unique populations after COVID-19, such as competitive athletes with a heightened risk of sudden cardiac death, patients with multisystem inflammatory syndrome, and people suspected of having COVID-19 vaccine-induced myocarditis. This review summarises the key attributes of CMR, reviews the literature that has emerged for using CMR for people who may have COVID-19-related complications after COVID-19, and offers expert opinion regarding future avenues of investigation and the importance of reporting findings.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Experimental Studies
/
Prognostic study
Topics:
Vaccines
Language:
English
Journal:
Card Fail Rev
Year:
2022
Document Type:
Article
Affiliation country:
Cfr.2021.20
Similar
MEDLINE
...
LILACS
LIS